Hospital Clinico San Carlos

Madrid, Madrid 28040

2 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumor, Alzheimer Disease, Atrial Fibrillation, Bleeding, Coronary Artery Disease, KRAS G12C-mutated Solid Tumors, Lung Cancer, KRAS, NRAS, HRAS-mutated NSCLC, Kidney Transplantation, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer, Non-Small Cell Lung Cancer, NSCLC, RAS G12D-mutated NSCLC, Stroke

Studies at this site

• Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC — Recruiting now
• A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors — Recruiting now
• XIENCE Skypoint Large Vessel Post Approval Study — Running, not enrolling
• Amplatzer Amulet LAAO vs. NOAC — Running, not enrolling
• Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients — Stopped early
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis — Completed
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• Freedom Study: Myfortic in Kidney Transplant Patients — Completed